![Shahid Abbasi: Xylexa has joined the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering](https://oncodaily.com/pub/uploads/2024/06/81593476427.png)
Shahid Abbasi: Xylexa has joined the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering
Shahid Abbasi, Co-Founder of Xylexa, recently shared on LinkedIn:
“I am pleased to announce that Xylexa, Inc., has officially joined the Industrial Participant Program of the Wyss Institute for Biologically Inspired Engineering at Harvard University’s Diagnostics Accelerator.
This esteemed program functions as a collaborative hub between healthcare diagnostics companies and the scientific and clinical community within the Wyss ecosystem. We are honored to be part of this prestigious initiative and are committed to advancing the field of medical diagnostics through this valuable partnership.
Xylexa assists Radiologists and Caregivers with accurate, timely, and cost-effective medical image interpretation. With 11 awards/accolades received and 9 platform implementations, Xylexa is well on its way to obtaining FDA approval within the year.”
Read further
Source: Shahid Abbasi/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023